Follow
Sarah L Inwood
Sarah L Inwood
Unknown affiliation
No verified email - Homepage
Title
Cited by
Cited by
Year
Fed-batch high-cell-density fermentation strategies for Pichia pastoris growth and production
WC Liu, S Inwood, T Gong, A Sharma, LY Yu, P Zhu
Critical reviews in biotechnology 39 (2), 258-271, 2019
942019
Identifying HIPK1 as target of miR‐22‐3p enhancing recombinant protein production from HEK 293 cell by using microarray and HTP siRNA screen
S Inwood, E Buehler, M Betenbaugh, M Lal, J Shiloach
Biotechnology journal 13 (2), 1700342, 2018
202018
Towards quantitative and standardized serological and neutralization assays for COVID-19
L Tian, EB Elsheikh, PN Patrone, AJ Kearsley, AK Gaigalas, S Inwood, ...
International journal of molecular sciences 22 (5), 2723, 2021
182021
Progressing from transient to stable packaging cell lines for continuous production of lentiviral and gammaretroviral vectors
J Park, S Inwood, S Kruthiventi, J Jenkins, J Shiloach, M Betenbaugh
Current opinion in chemical engineering 22, 128-137, 2018
182018
Methods for using small non-coding RNAs to improve recombinant protein expression in mammalian cells
S Inwood, MJ Betenbaugh, J Shiloach
Genes 9 (1), 25, 2018
142018
Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1
S Inwood, L Abaandou, M Betenbaugh, J Shiloach
New biotechnology 54, 28-33, 2020
112020
TrichoGate: An Improved Vector System for a Large Scale of Functional Analysis of Trichoderma Genes
G Nogueira-López, F Padilla-Arizmendi, S Inwood, S Lyne, JM Steyaert, ...
Frontiers in Microbiology 10, 2794, 2019
102019
Genome-wide high-throughput rnai screening for identification of genes involved in protein production
S Inwood, MJ Betenbaugh, M Lal, J Shiloach
Recombinant Protein Expression in Mammalian Cells: Methods and Protocols …, 2018
92018
Continuous production process of retroviral vector for adoptive T-cell therapy
S Inwood, H Xu, MA Black, MJ Betenbaugh, S Feldman, J Shiloach
Biochemical engineering journal 132, 145-151, 2018
22018
Evaluation protocol for CRISPR/Cas9-mediated CD19 knockout GM24385 cells by flow cytometry and Sanger sequencing
SL Inwood, L Tian, K Parratt, S Maragh, L Wang
Biotechniques 72 (6), 279-286, 2022
12022
Stochastic Reaction–Diffusion Model of the Binding of Monoclonal Antibodies to CD4 Receptors on the Surface of T Cells
L Wang, PC DeRose, SL Inwood, AK Gaigalas
International Journal of Molecular Sciences 21 (17), 6086, 2020
12020
Analysis of stability CRISPR/Cas9 engineered B cells using flow cytometry
SL Inwood, L Tian, S Maragh, L Wang
The Journal of Immunology 204 (1_Supplement), 91.32-91.32, 2020
2020
Proteomic and Genomic Analysis of CRISPR/Cas9 Engineered Cells and Their Stability
SL Inwood, L Tian, S Maragh, L Wang
MOLECULAR THERAPY 28 (4), 284-285, 2020
2020
Using intrinsic and extrinsic methods to engineer improved expression of recombinant proteins and retroviral vectors in mammalian cell
S Inwood
The Johns Hopkins University, 2018
2018
Identified genes involved in improving recombinant protein expression from HEK 293 cells by miRNA 22-3p
S Inwood, M Betenbaugh, J Shiloach
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
Improving production of retroviral vector from Pg13 cells for T cell therapy
J Shiloach, S Inwood, M Betenbaugh, S Feldman
2017
The system can't perform the operation now. Try again later.
Articles 1–16